Fig. 2From: A rodent model of anterior ischemic optic neuropathy (AION) based on laser photoactivation of verteporfinFlash-Visual Evoked Potentials (F-VEPs) in AION. F-VEP amplitudes of P1 in treated eyes measured 87.3 ± 11% of the fellow control eyes at 1 week, 67.6 ± 11.5% at 2 week, and 35.9 ± 13.6% at 3 week. We did not compare F-VEP latencies in the two data sets because of the indistinctive statistics. (*P < 0.05 in the 14d and 21d groups compared with the sham group, N = 6 in each group)Back to article page